echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Food News > Nutrition News > For colorectal cancer patients receiving the Medium Emetic Chemotherapy (MEC) FOLFOX regimen, aprepitant instead of dexamethasone is more effective in preventing CINV in combination with Palonosetrone

    For colorectal cancer patients receiving the Medium Emetic Chemotherapy (MEC) FOLFOX regimen, aprepitant instead of dexamethasone is more effective in preventing CINV in combination with Palonosetrone

    • Last Update: 2022-10-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, the team of Deng Yanhong of the Cancer Center of the Sixth Affiliated Hospital of Sun Yat-sen University (hereinafter referred to as "Zhongshan Sixth Hospital") completed a prospective phase III clinical study


    The team demonstrated for the first time that for colorectal cancer patients receiving a moderate emetic chemotherapy (MEC) FOLFOX regimen, aprepitant instead of dexamethasone in combination with Palonosetron was more effective in preventing CINV


    Dexamethasone is a glucocorticoid widely used to prevent and treat CINV


    The relevant research results were recently published in eClinicalMedicine (IF=17.


    In this study, the research team also exploratorily analyzed the changes in the number of peripheral blood cells before and after the first cycle of chemotherapy, and observed that the frequency of B cell decline in the DP group was more than that in the AP group, and the difference did not reach statistical significance (58.


    All in all, in patients receiving the MEC regimen, aprepitant combined with Palonosetron was superior to dexamethasone plus parlonosesetron




    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.